Novel EGFR-Mutant Mouse Models of Lung Adenocarcinoma Reveal Adaptive Immunity Requirement for Durable Osimertinib Response
L. E. Heasley, E. K. Kleczko, A. T. Le, T. K. Hinz, T. T. Nguyen, A. Navarro, C.-J. Hu, E. T. Clambey, D. T. Merrick, M. Weiser-Evans, R. A. Nemenoff
bioRxiv · Oct 26, 2022Cancer Biology